Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 2, 2006, Pages

  Yu, Zhiyuan ^a   Kone, Bruce C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Epigenetic; Nitric oxide; Transcription

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HISTONE H4; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LUCIFERASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; S6 KINASE; THREONINE; TRICHOSTATIN A; ENZYME INHIBITOR; HISTONE; HYDROXAMIC ACID; NOS2 PROTEIN, MOUSE;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INDUCTION; ENZYME INHIBITION; GENE CONTROL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CHEMISTRY; CHROMATIN; DRUG EFFECT; GENETICS; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACETYLATION; ANIMALS; CHROMATIN; ENZYME INHIBITORS; HISTONES; HYDROXAMIC ACIDS; INTERLEUKIN-1; MESANGIAL CELLS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TRANSFECTION;

EID: 33644862022     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00316.2005     Document Type: Article

References (37)

1. Ashburner BP, Westerheide SD, and Baldwin AS Jr. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065-7077, 2001.
2. Astrand C, Klenka T, Wrange O, and Belikov S. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. Eur J Biochem 271: 1153-1162, 2004.
3. Beck KF and Sterzel RB. Cloning and sequencing of the proximal promoter of the rat iNOS gene activation of NF-κB is not sufficient for transcription of the iNOS gene in rat mesangial cells. FEBS Lett 394: 263-267, 1996.
4. Boekhoudt GH, Guo Z, Beresford GW, and Boss JM. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J Immunol 170: 4139-4147, 2003.
5. Brownell JE and Allis CD. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6: 176-184, 1996.
6. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, and Kaelin WG Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4: 147-158, 2003.
7. Cattell V. Nitric oxide and glomerulonephritis. Semin Nephrol 19: 277-287, 1999.
8. Chen J, Halappanavar SS, St-Germain JR, Tsang BK, and Li Q. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell Mol Life Sci 61: 1675-1683, 2004.
9. Chen LF and Greene WC. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J Mol Med 81: 549-557, 2003.
10. Cheung P, Allis CD, and Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 103: 263-271, 2000.
11. Csiszar A, Pacher P, Kaley G, and Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol 3: 285-291, 2005.
12. Desilets A, Gheorghiu I, Yu SJ, Seidman EG, and Asselin C. Inhibition by deacetylase inhibitors of IL-1-dependent induction of haptoglobin involves CCAAT/Enhancer-binding protein isoforms in intestinal epithelial cells. Biochem Biophys Res Commun 276: 673-679, 2000.
13. Diaz-Guerra MJ, Castrillo A, Martin-Sanz P, and Bosca L. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J Immunol 162: 6184-6190, 1999.
14. Eberhardt W, Pluss C, Hummel R, and Pfeilschifter J. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells. J Immunol 160: 4961-4969, 1998.
15. Gao J, Morrison DC, Parmely TJ, Russell SW, and Murphy WJ. An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 272: 1226-1230, 1997.
16. Goto S, Yamamoto T, Feng LL, Yaoita E, Hirose S, Fujinaka H, Kawasaki K, Hattori R, Yui YS, Wilson CB, Arakawa M, and Kihara I. Expression and localization of inducible nitric oxide synthase in anti-Thy 1 glomerulonephritis. Am J Pathol 147: 1133-1141, 1995.
17. Greene WC and Chen LF. Regulation of NF-κB action by reversible acetylation. Novartis Found Symp 259: 208-225, 2004.
18. Hassan AH, Neely KE, Vignali M, Reese JC, and Workman JL. Promoter targeting of chromatin-modifying complexes. Front Biosci 6: D1054-D1064, 2001.
19. Hattori Y, Hattori S, and Kasai K. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-κB activation. Eur J Pharmacol 481: 153-158, 2003.
20. Kone BC and Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol Renal Physiol 272: F561-F578, 1997.
21. Kristof AS, Marks-Konczalik J, Billings E, and Moss J. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-γ is regulated by mammalian target of rapamycin. J Biol Chem 278: 33637-33644, 2003.
22. Pahan K, Raymond JR, and Singh I. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J Biol Chem 274: 7528-7536, 1999.
23. Pfeilschifter J and Vosbeck K. Transforming growth factor beta 2 inhibits interleukin 1 β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175: 372-379, 1991.
24. Quivy V and Van Lint C. Regulation at multiple levels of NF-κB-mediated transactivation by protein acetylation. Biochem Pharmacol 68: 1221-1229, 2004.
25. Rohde JR and Cardenas ME. The tor pathway regulates gene expression by linking nutrient sensing to histone acetylation. Mol Cell Biol 23: 629-635, 2003.
26. Salh B, Wagey R, Marotta A, Tao JS, and Pelech S. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J Immunol 161: 6947-6954, 1998.
27. Sasahara Y, Mutoh M, Takahashi M, Fukuda K, Tanaka N, Sugimura T, and Wakabayashi K. Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells. Cancer Lett 177: 155-161, 2002.
28. Saura M, Martinez Dalmau R, Minty A, Perez Sala D, and Lamas S. Interleukin 13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem J 313: 641-646, 1996.
29. Strahl BD and Allis CD. The language of covalent histone modifications. Nature 403: 41-45, 2000.
30. Van Lint C, Emiliani S, and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5: 245-253, 1996.
31. Wang C, Wang MW, Tashiro S, Onodera S, and Ikejima T. Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. J Pharm Sci 97: 494-500, 2005.
32. Wilson MA, Ricci AR, Deroo BJ, and Archer TK. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. J Biol Chem 277: 15171-15181, 2002.
33. Withers DJ, Ouwens DM, Nave BT, van der Zon GC, Alarcon CM, Cardenas ME, Heitman J, Maassen JA, and Shepherd PR. Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun 241: 704-709, 1997.
34. Xie Qw Kashiwabara Y and Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994.
35. Yu Z and Kone BC. Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription. J Biol Chem 279: 46954-46961, 2004.
36. Yu Z, Zhang W, and Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol 13: 2009-2017, 2002.
37. Yu Z, Zhang W, and Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem J 367: 97-105, 2002.